or Try an Advanced Search...

    Technical Analysis for TIL - Instil Bio, Inc.

    Grade Last Price % Change Price Change
    C 10.71 0.66% 0.07
    TIL closed up 0.66 percent on Monday, April 22, 2024, on 44 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Flat
    Historical TIL trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 2.88%
    Gapped Down Weakness 2.88%
    Slingshot Bearish Bearish Swing Setup 1.18%
    Gapped Up Strength 1.18%
    Narrow Range Bar Range Contraction 3.68%
    Down 3 Days in a Row Weakness 3.68%
    Gapped Down Weakness 3.68%
    Gapped Down Weakness 2.59%
    Hammer Candlestick Bullish -1.70%
    Spinning Top Other -3.16%
    Older End-of-Day Signals for TIL ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 16 hours ago
    Gap Down Closed about 21 hours ago
    Reversed from Down about 21 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    Rose Above Previous Day's High about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TIL Chart by TradingView
    Basic chart:

    Profile

    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Oncology Cancer Immunotherapy Cell Therapy Non Small Cell Lung Cancer Melanoma Lymphocytes Cervical Cancer Head And Neck Squamous Cell Carcinoma Tumor Infiltrating Lymphocytes Cutaneous Squamous Cell Carcinoma Therapies For The Treatment Of Patients With Cancer

    Is TIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 12 Jefferies cuts Instill Bio to hold, cites drug discontinuation
    Mar 27 What Makes Instil Bio (TIL) a New Buy Stock
    Mar 22 Instil Bio Non-GAAP EPS of -$1.26 beats by $2.14
    Mar 21 Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    Jan 18 Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
    Jan 17 Instil Bio hits four-month high on rising volumes
    Jan 16 Instil Bio Announces Strategic Update
    Dec 5 Instil Bio announces effective date of 1-for-20 reverse stock split
    Dec 5 Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split
    Nov 14 Instil Bio Non-GAAP EPS of -$0.16 misses by $0.01
    See more TIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.0
    52 Week Low 6.07
    Average Volume 14,914
    200-Day Moving Average 9.50
    50-Day Moving Average 11.47
    20-Day Moving Average 10.80
    10-Day Moving Average 10.69
    Average True Range 0.42
    RSI (14) 44.75
    ADX 20.66
    +DI 18.80
    -DI 20.46
    Chandelier Exit (Long, 3 ATRs) 10.93
    Chandelier Exit (Short, 3 ATRs) 11.42
    Upper Bollinger Bands 11.30
    Lower Bollinger Band 10.29
    Percent B (%b) 0.41
    BandWidth 9.39
    MACD Line -0.25
    MACD Signal Line -0.24
    MACD Histogram -0.0087
    Fundamentals Value
    Market Cap 69.66 Million
    Num Shares 6.5 Million
    EPS -30.20
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 55329.79
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 11.26
    Resistance 3 (R3) 11.22 11.00 11.17
    Resistance 2 (R2) 11.00 10.86 11.02 11.14
    Resistance 1 (R1) 10.86 10.77 10.93 10.89 11.11
    Pivot Point 10.63 10.63 10.67 10.65 10.63
    Support 1 (S1) 10.49 10.49 10.56 10.53 10.31
    Support 2 (S2) 10.27 10.41 10.28 10.28
    Support 3 (S3) 10.12 10.27 10.25
    Support 4 (S4) 10.16